Botanical species · safety record

Smilax aspera

The EFSA Compendium of Botanicals holds 3 constituent measurements for Smilax aspera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Smilax aspera L.

3Constituent measurements

0Safety records

3Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Smilax aspera as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Steroidal furostan saponins	Roots and other underground parts	Solvent extraction	—	GC-MS	Resolve DOI
Melatonin	Leaves	Solvent extraction	443 Picogram/gram	Enzyme-linked immunosorbent assay (ELISA)	No resolvable identifier
Steroidal saponins	Roots and other underground parts	Solvent extraction	—	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Zohar, Ram., Izhaki, Ido., Koplovich, Avi., Ben-Shlomo, Rachel. Phytomelatonin in the leaves and fruits of wild perennial plants. Phytochemistry letters, 2011, vol. 4, no. 3, p. 222-226.
Belhouchet, Z., Sautour, M., Miyamoto, T., Lacaille-Dubois, M. A. Steroidal saponins from the roots of Smilax aspera subsp mauritanica. Planta medica, 2008, vol. 74, no. 9, p. 1033-1034.
Ivanova, Antoaneta., Mikhova, Bozhanka., Batsalova, Tsvetelina., Dzhambazov, Balik., Kostova, Ivanka. New furostanol saponins from Smilax aspera L. and their in vitro cytotoxicity . Fitoterapia, 2011, vol. 82, no. 2, p. 282-287. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature